Imperial College London

Dr. Ramzi Y Khamis MB ChB PhD FESC FRCP

Faculty of MedicineNational Heart & Lung Institute

Clinical Senior Lecturer in Cardiology
 
 
 
//

Contact

 

+44 (0)20 7594 6842r.khamis

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Summary

Dr. Ramzi Khamis  is a Clinical Senior Lecturer in Cardiology and a  consultant cardiologist, with a subspecialty in interventional cardiology.  Ramzi is the Clinical Director for Cardiology and Cardiac Surgery at Imperial College Healthcare NHS Trust.  He also leads the high risk atherosclerosis clinic at Imperial college Healthcare NHS Trust. 

Ramzi holds  a Fellowship from the  British Heart Foundation as a clinician scientist in Cardiovascular Medicine.  He undertakes both his clinical and research work at the Hammersmith Hospital Campus. 

Dr. Khamis was trained in general cardiology, interventional cardiology and translational cardiovascular medicine at Imperial College and its affiliated hospitals. Dr. Khamis completed his interventional cardiology fellowships  at the Hammersmith Hospital. He was awarded his consultant level accreditation (CCT) in both G(I)M and cardiology from the Royal College Of Physicians, and PhD from Imperial college London in 2014.  Dr. Khamis is also a fellow of the European Society of Cardiology (FESC). Dr. Khamis first graduated from Bristol in 2000, and undertook his House Officer training at Bristol and Bath followed by Emergency Medicine training in Leeds, and then by General Internal Medicine training as part of  the Barts and the London Medical SHO training scheme in London. Dr. Khamis  also taught physiology at Bristol University as a tutor in 2002.

He was awarded and completed a highly competitive Academic Clinical Fellowship in Cardiology, encompassing both clinical and academic training,  funded by the National Institute for Health Research (NIHR) at the National Heart and Lung Institute, as well as competitive  Fellowships in Interventional Cardiology at the Hammersmith Hospital London in 2009-10 and 2013-14.  He was also awarded a Wellcome Trust/ GSK Clinical Research Fellowship in Translational Medicine, undertaking his PhD under the Supervision of Profs Haskard and Matthews. 

His research interests include the development of a multimodality imaging strategy for the detection of vulnerable plaque in atherosclerosis, developing  novel biomarkers in cardiovascular risk assessment and the understanding the role of antibodies in atherosclerosis. 

In 2014, Dr Khamis was the winner of the British Cardiovascular Society Young Research Worker of the Year Award and  a finalist at the American College of Cardiology Young Investigator of the Year Award. He was also British Atherosclerosis Society  Young Investigator of the Year finalist 2013 and the winner of the British Atherosclerosis Binks travel award (Harvard Medical School) 2013.

Dr. Khamis group encompasses both clinicians and scientists focusing on the targeting of oxidised LDL in atherosclerosis using interventional and non interventional  modalities such as near infra-red fluorescence (NIRF) imaging and positron emission tomography (PET). He also undertakes research to explore the mechanistic link between the humeral immune system and atherosclerosis. Dr. Khamis' group are developing  various serological tests to better risk stratify cardiac risk in patients and populations. 

During COVID-19 pandemic, Ramzi's efforts were on the COVID reposes and was the co-head of cardiology at Imperial College HNT.  

Dr. Khamis co-organised the Imperial College COVID-19 Cardiovascular Conference which highlights the current knowledge and cumulative experience to date , on 2 April 2020. Click here to watch the recording
Support the BHF

 

 

Publications

Journals

Naderi H, Robinson S, Swaans MJ, et al., 2021, Adapting the role of handheld echocardiography during the COVID-19 pandemic: A practical guide., Perfusion

Ono M, Tomaniak M, Koenig W, et al., 2020, Impact of White Blood Cell Count on Clinical Outcomes in Patients Treated with Aspirin-Free Ticagrelor Monotherapy after Percutaneous Coronary Intervention: Insights from the GLOBAL LEADERS Trial., Eur Heart J Cardiovasc Pharmacother

Abdelrahman KM, Chen MY, Dey AK, et al., 2020, Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review., J Am Coll Cardiol, Vol:76, Pages:1226-1243

Conference

Little C, Jabbour R, Kotecha T, et al., 2020, Primary PCI for STEMI During the COVID-19 Pandemic in London: A Systematic Analysis of Pathway Activation and Outcomes, 32nd Annual Transcatheter Cardiovascular Therapeutics Symposium (TCT CONNECT), ELSEVIER SCIENCE INC, Pages:B96-B96, ISSN:0735-1097

Rajkumar C, Shun-Shin M, Seligman H, et al., 2020, Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease: A Secondary Analysis From ORBITA, 32nd Annual Transcatheter Cardiovascular Therapeutics Symposium (TCT CONNECT), ELSEVIER SCIENCE INC, Pages:B165-B165, ISSN:0735-1097

More Publications